Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 4
2014 1
2015 2
2016 1
2017 1
2018 2
2019 6
2020 10
2021 15
2022 15
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
Relatlimab and Nivolumab versus Nivolumab in Untreated Advanced Melanoma.
Tawbi HA, Schadendorf D, Lipson EJ, Ascierto PA, Matamala L, Castillo Gutiérrez E, Rutkowski P, Gogas HJ, Lao CD, De Menezes JJ, Dalle S, Arance A, Grob JJ, Srivastava S, Abaskharoun M, Hamilton M, Keidel S, Simonsen KL, Sobiesk AM, Li B, Hodi FS, Long GV; RELATIVITY-047 Investigators. Tawbi HA, et al. N Engl J Med. 2022 Jan 6;386(1):24-34. doi: 10.1056/NEJMoa2109970. N Engl J Med. 2022. PMID: 34986285 Free PMC article. Clinical Trial.
Combined anti-PD-1 and anti-CTLA-4 checkpoint blockade: Treatment of melanoma and immune mechanisms of action.
Willsmore ZN, Coumbe BGT, Crescioli S, Reci S, Gupta A, Harris RJ, Chenoweth A, Chauhan J, Bax HJ, McCraw A, Cheung A, Osborn G, Hoffmann RM, Nakamura M, Laddach R, Geh JLC, MacKenzie-Ross A, Healy C, Tsoka S, Spicer JF, Josephs DH, Papa S, Lacy KE, Karagiannis SN. Willsmore ZN, et al. Among authors: papa s. Eur J Immunol. 2021 Mar;51(3):544-556. doi: 10.1002/eji.202048747. Epub 2021 Feb 23. Eur J Immunol. 2021. PMID: 33450785 Free article. Review.
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE; ICPi-AKI Consortium Investigators. Gupta S, et al. J Immunother Cancer. 2021 Oct;9(10):e003467. doi: 10.1136/jitc-2021-003467. J Immunother Cancer. 2021. PMID: 34625513 Free PMC article.
Utilizing Immunocytokines for Cancer Therapy.
Runbeck E, Crescioli S, Karagiannis SN, Papa S. Runbeck E, et al. Among authors: papa s. Antibodies (Basel). 2021 Mar 9;10(1):10. doi: 10.3390/antib10010010. Antibodies (Basel). 2021. PMID: 33803078 Free PMC article. Review.
New Developments in Imaging Cell-Based Therapy.
Martinez O, Sosabowski J, Maher J, Papa S. Martinez O, et al. Among authors: papa s. J Nucl Med. 2019 Jun;60(6):730-735. doi: 10.2967/jnumed.118.213348. Epub 2019 Apr 12. J Nucl Med. 2019. PMID: 30979822 Free PMC article. Review.
Dynamic imaging for CAR-T-cell therapy.
Emami-Shahri N, Papa S. Emami-Shahri N, et al. Among authors: papa s. Biochem Soc Trans. 2016 Apr 15;44(2):386-90. doi: 10.1042/BST20150257. Biochem Soc Trans. 2016. PMID: 27068944 Review.
Intratumoral pan-ErbB targeted CAR-T for head and neck squamous cell carcinoma: interim analysis of the T4 immunotherapy study.
Papa S, Adami A, Metoudi M, Beatson R, George MS, Achkova D, Williams E, Arif S, Reid F, Elstad M, Beckley-Hoelscher N, Douri A, Delord M, Lyne M, Shivapatham D, Fisher C, Hope A, Gooljar S, Mitra A, Gomm L, Morton C, Henley-Smith R, Thavaraj S, Santambrogio A, Andoniadou C, Allen S, Gibson V, Cook GJR, Parente-Pereira AC, Davies DM, Farzaneh F, Schurich A, Guerrero-Urbano T, Jeannon JP, Spicer J, Maher J. Papa S, et al. J Immunother Cancer. 2023 Jun;11(6):e007162. doi: 10.1136/jitc-2023-007162. J Immunother Cancer. 2023. PMID: 37321663 Free PMC article.
PanErbB-targeted CAR T-cell immunotherapy of head and neck cancer.
Larcombe-Young D, Papa S, Maher J. Larcombe-Young D, et al. Among authors: papa s. Expert Opin Biol Ther. 2020 Sep;20(9):965-970. doi: 10.1080/14712598.2020.1786531. Epub 2020 Jun 28. Expert Opin Biol Ther. 2020. PMID: 32567382 No abstract available.
BRAF inhibitors and their immunological effects in malignant melanoma.
Adams R, Coumbe JEM, Coumbe BGT, Thomas J, Willsmore Z, Dimitrievska M, Yasuzawa-Parker M, Hoyle M, Ingar S, Geh JLC, MacKenzie Ross AD, Healy C, Papa S, Lacy KE, Karagiannis SN. Adams R, et al. Among authors: papa s. Expert Rev Clin Immunol. 2022 Apr;18(4):347-362. doi: 10.1080/1744666X.2022.2044796. Epub 2022 Mar 3. Expert Rev Clin Immunol. 2022. PMID: 35195495 Review.
59 results